(Q33990203)

30 July 2017

1 reference

title

Molecular pathways leading to cancer cachexia (English)

1 reference

30 July 2017

Michael J Tisdale

1

1 reference

30 July 2017

1 October 2005

1 reference

30 July 2017

1 reference

30 July 2017

20

1 reference

30 July 2017

340-348

1 reference

Cancer cachexia is regulated by selective targeting of skeletal muscle gene products

30 July 2017

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Identification of ubiquitin ligases required for skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Hyperlipemia: a role in regulating UCP3 gene expression in skeletal muscle during cancer cachexia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Induction of cachexia in mice by a product isolated from the urine of cachectic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Muscle UCP-3 mRNA levels are elevated in weight loss associated with gastrointestinal adenocarcinoma in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Anticytokine treatment prevents the increase in the activity of ATP-ubiquitin- and Ca(2+)-dependent proteolytic systems in the muscle of tumour-bearing rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Cardiovascular and metabolic response to adrenaline infusion in weight-losing patients with and without cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

The Sir David Cuthbertson Medal Lecture 1991. The mechanisms and treatment of weight loss in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Acute treatment with tumour necrosis factor-alpha induces changes in protein metabolism in rat skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Proceedings: Causes of death in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Body-composition changes in patients who gain weight while receiving megestrol acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Induction of muscle protein degradation by a tumour factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Skeletal muscle metabolism in patients with malignant tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Rounding of low serum creatinine levels and consequent impact on accuracy of bedside estimates of renal function in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Tumors secreting human TNF/cachectin induce cachexia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Induction of lipolysis in vitro and loss of body fat in vivo by zinc-alpha2-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Effect of zinc-alpha2-glycoprotein (ZAG) on expression of uncoupling proteins in skeletal muscle and adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Fatty acid and glycerol kinetics in septic patients and in patients with gastrointestinal cancer. The response to glucose infusion and parenteral feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Brown adipose tissue in cancer patients: possible cause of cancer-induced cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Evidence for the involvement of interleukin 6 in experimental cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Increased expression of the mRNA for hormone-sensitive lipase in adipose tissue of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Characterization of a cancer cachectic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Structural analysis of a tumor-produced sulfated glycoprotein capable of initiating muscle protein degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

The relationship between a urinary cachectic factor and weight loss in advanced cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Risk factors for postoperative pneumonia. The importance of protein depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Regulation of protein synthesis by branched-chain amino acids in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

Anti-interferon-γ antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00019.2005

10.1152/PHYSIOL.00019.2005

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

16174873